Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.

Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.

Abstract: A bed frame comprising T-shaped side rails provides support for a box spring and mattress. The T-shaped side rails provide more resistance to twisting and bowing and enables the overall bed frame to support more weight with less deflection than the convention L-shaped side rails. The T-shaped side rails may be two L-shaped angle irons affixed together or a unitary T-shaped member that can also be used for other structural components of the bed frame such as a center beam. The vertical flange of the T-shape can be non-linear. In a further embodiment, the side rails are comprised of a metal skin enclosing a hollow area with a horizontal, flat shelf for supporting the box spring and a contiguous vertical surface generally at a right angle to the horizontal shelf to retain the box spring in it desired position.

Abstract: The present invention refers to a gene transfer system for stably introducing nucleic acid(s) into the DNA of a cell by using a member of the human mariner transposases. The invention further refers to this transposase and to transposons used in the inventive gene transfer system, comprising a nucleic acid sequence with flanking repeats (IRs and/or IR/DRs). Furthermore, applications of this gene transfer system are also disclosed such as gene therapy, insertional mutagenesis, gene discovery (including genome mapping), mobilization of genes, library screening, or functional analysis of genomes in vivo and in vitro. Finally, pharmaceutical compositions and kits are also encompassed.

Abstract: Novel imidazolopyridine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Abstract: The invention features a method for promoting neural growth in vivo in the mammalian central nervous system by administering a neural cell adhesion molecule which can overcome inhibitory molecular cues found on glial cells and myelin to promote neural growth. Also featured active fragments, cognates, congeners, mimics, analogs, secreting cells and soluble molecules thereof, as well as antibodies thereto, and DNA molecules, vectors and transformed cells capable of expressing them. The neuroprotective of the agents as well as their ability to promote and effect myelination and remyelination are also disclosed, as are the concomitant benefits that these capabilities confer, in the former instance, with regard to reduction of apoptosis and necrosis, and in the latter instance, the treatment of Parkinsonism, Alzheimer's disease and multiple sclerosis. The invention also includes transgenic mouse lines expressing a neural adhesion molecule in differentiated astrocytes, and cells and tissues derived therefrom.

Abstract: The present invention relates to a composition useful for the diagnosis and therapy of diseases associated with aberrant expression of the gene encoding the receptor Kremen 1 and/or Kremen 2 e.g. tumors or diseases of the kidneys, bones and eyes, lipid and glucose metabolism and obesity. The present invention also relates to a pharmaceutical composition containing a compound which is capable of modifying (a) the expression of the gene encoding Kremen 1 and/or Kremen 2 or (b) the activity of the Kremen 1 and/or Kremen 2 receptor.

Abstract: The present invention relates to a method of diagnosing an infertility condition in a human female subject, the method comprising detecting pregnancy-related serine protease (PRSP) protein in a test sample taken from said subject at between 7 and 20 weeks into pregnancy; detecting PRSP protein in a test sample from a fertile control mammal taken within the same period; and comparing the PRSP protein in the test sample with the PRSP protein detected in the control sample, wherein a change in PRSP protein in the sample compared to the control sample is indicative of an infertility condition.

Abstract: Methods and compositions for modulating the mobilization of stem cells, particularly for promoting or increasing the mobilization of hematopoietic stem cells from the bone marrow to the peripheral blood are disclosed. In particular, the invention relates to the use of adrenergic agonists that act in concert with a mobilization compound or agent. The mobilization agent(s) may act to decrease the expression or function of the chemokine, CXCL12, or may act to block or antagonize CXCR4. The invention also relates to methods of using these compounds or agents for enhancing the mobilization of hematopoietic stem cells when harvesting of the stem cells is necessary for the treatment of diseases, disabilities or conditions whereby transplantation of such cells would be beneficial in ameliorating the symptoms associated with such diseases, disabilities or conditions. Methods of screening for novel agents and pharmaceutical compositions comprising these agents are also disclosed.

Abstract: Opening and secure-closing system for doors comprising two doors (1,2) for accessing the interior of a chamber, which open towards the outside being hinged around two hinging axes (19,20), both doors (1,2) comprising a set of bolts (17,18) and the opening and closing system comprising additional means of opening/closing operation (26) and an overpressure door (3) located in one of the doors (1,2) which opens towards the outside, in such a way that the means of opening/closing operation (26) comprise a blocking bar (4), a blocking fitting (7) and means of retention (10) between the two doors (1,2) in order to provide a controlled and sequential opening/closing operation of the chamber, and the overpressure door (3) is opened automatically in the event of emergency due to overpressure, and it also participates in the controlled and sequential opening/closing operation of the chamber.

Abstract: The invention relates to a process for the controlled amplification of at least one part of a starting DNA containing a plurality of restriction sites for a determined specific restriction endonuclease, and of which at least part of its nucleic acid is unknown. This technology can be applied to human, animal or plant DNA fingerprinting, to identify restriction fragment length polymorphisms. Also encompassed by the inventive technology are kits for the application of the process.

Abstract: The present invention relates to the expression and regulating growth factors in chrondrocytes and developing cartilage, particularly granulin-epithelin precursor (GEP). The invention relates to the modulation and manipulation of these growth factors, GEP, and/or the molecules they interact with, for instance COMP, in cartilage disorders, including arthritis. Assays and screening methods for the determination of the expression and activity of GEP, or of GEP-COMP, are provided, including for screening for the presence or extent of cartilage or arthritic disease and for identifying modulators or compounds/agents for treatment or prevention of cartilage or arthritic diseases.

Abstract: The present invention provides the structural determination of a bromodomain determined by NMR spectroscopy. The present invention also provides a binding partner for the bromodomain. In addition, the present invention provides methodology for related drug discovery using high throughput drug screening or structure based rational drug design using the three-dimensional data.

Abstract: Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.

Abstract: The invention relates to a method of preparing metallic nanoparticles and to the materials thus obtained. More specifically, the invention relates to a method of preparing metallic nanoparticles consisting in: selecting a precursor from the salts, hydroxides and oxides of metallic elements that can be reduced at temperatures below the clay silicate network destruction temperature; and depositing said precursor on a support selected from pseudolaminar phyllosilicate clays. According to the invention the method comprises: (i) a deposition step in which the precursor is deposited on the support: (ii) when the precursor is selected from among salts and hydroxides, a thermal decomposition step in a controlled atmosphere, in which the precursor is subjected to a decomposition process and is transformed into an oxide of the metallic element: and (iii) a reduction step in which the oxide of the metallic element is subjected to a reduction process in a controlled atmosphere.

Abstract: Support system suitable for sustaining an auxiliary power unit of an aircraft to a fixed structure (2) belonging to a compartment of the auxiliary power unit (6) of the aircraft. The support system is made in a high mechanical strength material and with high resistance to ignition, and comprises three fittings (3, 4, 5) two of which are frusto-conical and one with a substantially cylindrical. Fittings (3, 4, 5) being able to be hollow and being able to comprise an array of lateral ribs. Each one of them presenting a first end (7) comprising means of attachment of the support system (8) to the fixed structure (2) and a second end (9) comprising means of securing of the support system (8) which are joined to the auxiliary power unit (1) in the periphery of the extension of said auxiliary power unit (1).